Previous 10 | Next 10 |
The Hague, May 31, 2022 - Aegon N.V.’s Annual General Meeting (AGM) today approved all resolutions on the agenda, including adoption of the Annual Accounts for the financial year 2021 and a final dividend for 2021 of EUR 0.09 per common share, bringing Aegon’s total dividend f...
The Hague, May 23, 2022 - Aegon announces today it has decided to sell its 50% stake in the Spanish insurance joint venture with Liberbank to Unicaja Banco. The sale follows the change of control in Liberbank after its merger with Unicaja Banco in 2021. The gross proceeds of the transa...
Please click here to access all 1Q 2022 results related documents. The Hague, May 12, 2022 - Further prog ress o n transforming the company and achieving financial targets Net result increases by 7% compared with the first quarter of 2021 to EUR 412 milli...
The Hague, April 21, 2022 - Aegon Bank has today published its 2021 annual report. The report provides information on the bank’s strategy, governance, business, and financial performance on a statutory basis. The report is available for download here . About Aegon ...
The Hague, April 19, 2022 - Today, Aegon N.V. has published the agenda for its Annual General Meeting of Shareholders (AGM) on Tuesday, May 31, 2022. The Executive Board will propose to the AGM that shareholders adopt the Annual Accounts 202 1 and approve a final dividend for ...
The Hague, March 23, 2022 - Aegon announces today that it has completed the divestment of its Hungarian businesses to Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG). The gross proceeds of the transaction amount to EUR 620 million. This completion is an important step towards the...
The Hague, March 21, 2022 - Aegon will today file its 2021 Annual Report on Form 20-F with the United States Securities and Exchange Commission (SEC). The 2021 Annual Report on Form 20-F will be available on aegon.com and can be downloaded from the SEC website later today. Abo...
The Hague, March 17, 2022 - Aegon N.V. today published its 2021 Integrated Annual Report (IAR). The report provides an overview of its business, strategy, and its financial and non-financial performance. The report also reflects on the key trends that influence Aegon's businesses and its st...
The Hague, March 8, 2022 - Aegon has announced that it will not make future investments in Russia or Belarus-based companies and has updated its Responsible Investment Policy accordingly. This policy applies to all general account investments where Aegon has full management control. Investm...
The Hague, February 16, 2022 - Aegon has taken note of the announcement issued today by Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG) about the agreement reached between VIG and the Hungarian state holding Corvinus Nemzetközi Befektetési Zrt. (Corvinus) on the details...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET About to begin a phase 2b/3 multinational study of Ifenprodil Algernon Pharmaceuticals is a drug repurposing company. They're a phase 2 clinical stage company advancing a drug called Ifenprodil for idiopathic pulmonary fibrosis, but also as a potential thera...
2024-03-27 17:08:02 ET A stroke can be a devastating and debilitating event for an individual and their family, and a major burden on the health care system. Over 15 million people suffer strokes every year, and 85% of those have some form of disability as a result. Stroke-related cos...
2024-03-27 17:08:02 ET Stocks to Invest in: Healthcare Focused on the disease areas of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease Algernon is a drug re-purposing company that investigates safe, already approved drugs, inclu...